-+ 0.00%
-+ 0.00%
-+ 0.00%

VTV THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 3 CATT1 STUDY OF CADISEGLIATIN IN TYPE 1 DIABETES (T1D)

Reuters·10/05/2026 12:00:01

Please log in to view news